FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311159672> ?p ?o ?g. }

• W4311159672 endingPage "6743" @default.
• W4311159672 startingPage "6729" @default.
• W4311159672 abstract "Tumor growth depends on tumor cells and the tumor microenvironment, which are regulated by inflammation and immune responses. However, the roles of inflammation and immune status in hepatocellular carcinoma (HCC) remain unclear. The aim of this study was to evaluate the prognostic value of an inflammatory response- related gene signature associated with immune status, which may provide insight into new treatment options for HCC patients.Differentially expressed genes associated with inflammation were obtained from The Cancer Genome Atlas (TCGA), the Gene Expression Omnibus, and the Molecular Signatures Database. An inflammation-associated prognostic gene signature was constructed and validated using TCGA and the International Cancer Genome Consortium datasets, respectively, using LASSO Cox regression analysis. Log-rank was performed to compare the overall survival of low- and high-risk score cohorts. Immune cell infiltration and immune-related functions were analyzed using single-sample gene enrichment analysis. The structures of the drugs identified by the prognostic model were predicted using PubChem. The drugs sensitivity of bleomycin, simvastatin and zoledronate detected by CCK8 colorimetric assay. The mRNA levels of 7 genes in HCC after drug treatment analyzed via qRT-PCR.Inflammation-associated genes, including ITGA5, MEP1A, P2RX4, RIPK2, SLC7A1 and SRI, were identified and found to be associated with the prognosis of HCC. We further found that the high-risk patients experienced poor prognosis, which was observed to be an independent and significant risk factor for prognosis. Moreover, we observed elevated expression levels in multiple immune cell types and immune function. Lastly, we validated that bleomycin, simvastatin and zoledronate could regulate these genes in HCC.The inflammatory-response-associated gene signature could predict the prognosis and the immunological status of HCC patients. Additionally, bleomycin, simvastatin and zoledronate may represent potential drug candidates that could inhibit these genes. This may constitute a new approach for the treatment of HCC." @default.
• W4311159672 created "2022-12-24" @default.
• W4311159672 creator A5016657839 @default.
• W4311159672 creator A5028470766 @default.
• W4311159672 creator A5029818365 @default.
• W4311159672 creator A5037519871 @default.
• W4311159672 creator A5060169599 @default.
• W4311159672 creator A5064634229 @default.
• W4311159672 creator A5067086355 @default.
• W4311159672 creator A5085107736 @default.
• W4311159672 date "2022-12-01" @default.
• W4311159672 modified "2023-10-14" @default.
• W4311159672 title "A Novel Gene Signature Associated with Inflammatory Responses and Immune Status Assists in Prognosis and Intervention for Patients with HCC" @default.
• W4311159672 cites W1971208896 @default.
• W4311159672 cites W1971518754 @default.
• W4311159672 cites W1989216370 @default.
• W4311159672 cites W1995518402 @default.
• W4311159672 cites W2034981605 @default.
• W4311159672 cites W2073728422 @default.
• W4311159672 cites W2081406906 @default.
• W4311159672 cites W2091340549 @default.
• W4311159672 cites W2116554142 @default.
• W4311159672 cites W2117692326 @default.
• W4311159672 cites W2127248987 @default.
• W4311159672 cites W2137052325 @default.
• W4311159672 cites W2152897456 @default.
• W4311159672 cites W2157076315 @default.
• W4311159672 cites W2177405394 @default.
• W4311159672 cites W2199395783 @default.
• W4311159672 cites W2273006669 @default.
• W4311159672 cites W2346311283 @default.
• W4311159672 cites W2550322865 @default.
• W4311159672 cites W2560367415 @default.
• W4311159672 cites W2563924257 @default.
• W4311159672 cites W2621003511 @default.
• W4311159672 cites W2626033245 @default.
• W4311159672 cites W2756470947 @default.
• W4311159672 cites W2787553551 @default.
• W4311159672 cites W2795867722 @default.
• W4311159672 cites W2886416332 @default.
• W4311159672 cites W2918426281 @default.
• W4311159672 cites W2952311394 @default.
• W4311159672 cites W2968470226 @default.
• W4311159672 cites W2968553676 @default.
• W4311159672 cites W2971320602 @default.
• W4311159672 cites W2992211060 @default.
• W4311159672 cites W3013551968 @default.
• W4311159672 cites W3025022288 @default.
• W4311159672 cites W3033218405 @default.
• W4311159672 cites W3035486298 @default.
• W4311159672 cites W3045387409 @default.
• W4311159672 cites W3093534501 @default.
• W4311159672 cites W3106035297 @default.
• W4311159672 cites W3111834837 @default.
• W4311159672 cites W3117432912 @default.
• W4311159672 cites W3125775728 @default.
• W4311159672 cites W3130290615 @default.
• W4311159672 cites W3180882235 @default.
• W4311159672 cites W3203289704 @default.
• W4311159672 cites W3210005677 @default.
• W4311159672 cites W3213277274 @default.
• W4311159672 cites W3216012594 @default.
• W4311159672 cites W4200158019 @default.
• W4311159672 cites W4205326410 @default.
• W4311159672 cites W4205430541 @default.
• W4311159672 cites W4223543625 @default.
• W4311159672 cites W4225529913 @default.
• W4311159672 cites W4248515682 @default.
• W4311159672 cites W4281654150 @default.
• W4311159672 cites W4283706065 @default.
• W4311159672 cites W4292553490 @default.
• W4311159672 cites W54135016 @default.
• W4311159672 doi "https://doi.org/10.2147/jir.s390113" @default.
• W4311159672 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36536645" @default.
• W4311159672 hasPublicationYear "2022" @default.
• W4311159672 type Work @default.
• W4311159672 citedByCount "4" @default.
• W4311159672 countsByYear W43111596722023 @default.
• W4311159672 crossrefType "journal-article" @default.
• W4311159672 hasAuthorship W4311159672A5016657839 @default.
• W4311159672 hasAuthorship W4311159672A5028470766 @default.
• W4311159672 hasAuthorship W4311159672A5029818365 @default.
• W4311159672 hasAuthorship W4311159672A5037519871 @default.
• W4311159672 hasAuthorship W4311159672A5060169599 @default.
• W4311159672 hasAuthorship W4311159672A5064634229 @default.
• W4311159672 hasAuthorship W4311159672A5067086355 @default.
• W4311159672 hasAuthorship W4311159672A5085107736 @default.
• W4311159672 hasBestOaLocation W43111596721 @default.
• W4311159672 hasConcept C126322002 @default.
• W4311159672 hasConcept C143998085 @default.
• W4311159672 hasConcept C203014093 @default.
• W4311159672 hasConcept C2776914184 @default.
• W4311159672 hasConcept C502942594 @default.
• W4311159672 hasConcept C50382708 @default.
• W4311159672 hasConcept C71924100 @default.
• W4311159672 hasConcept C86803240 @default.
• W4311159672 hasConcept C8891405 @default.
• W4311159672 hasConceptScore W4311159672C126322002 @default.

• next